Help Hope Solutions announced the release of its latest podcast episode featuring founder Cristina Busu on “Entrepreneurs on ...
Stoke Therapeutics, Inc.: late-stage zorevunersen for SCN1A Dravet Syndrome with durable 3-year data, Phase 3 EMPEROR and ...
Bilingual Diabetes Education and Support Group HOLYOKE – Holyoke Medical Center will host an ongoing bilingual Diabetes ...
Six biotechs based in California, Massachusetts, Washington and Denmark had to halt drug development efforts this year. One ...
She was 13 years old and scared of the dark when she arrived at a residential treatment center that had promised her adoptive ...
Ecopipam, Emalex's investigational asset for pediatric Tourette syndrome (TS), is a first-in-class selective dopamine D1 receptor antagonist with FDA Orphan Drug and Fast Track designations. The late- ...
Sun Home Saunas, the Inc. 5000-ranked infrared sauna company (No. 20, 2025), today published its comprehensive 2026 infrared sauna buyer's guide evaluating eight models across six criteria: heat ...
FormBlends, a telehealth platform focused on medically supervised GLP-1 therapy and peptide research, today released its 2026 ...
After a year without data, the State Department released figures on PEPFAR, the program launched by George W. Bush and ...
To those who knew him, Noah Silver was a bright, happy child identified as gifted with a penchant for playing instruments. He ...
Researchers at The University of Osaka have developed and evaluated a new eight-week training program that enables psychology trainees to effectively learn cognitive behavioral therapy (CBT) by ...
A guitar teacher in Michigan has launched an occupational therapy program to help people with Parkinson's disease play the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results